COSCIENS Biopharma Inc. (CSCI)
NASDAQ: CSCI · Real-Time Price · USD
3.040
0.00 (0.00%)
At close: Mar 28, 2025, 4:00 PM
3.209
+0.169 (5.56%)
After-hours: Mar 28, 2025, 6:30 PM EDT
COSCIENS Biopharma Market Cap
COSCIENS Biopharma has a market cap or net worth of $11.31 million as of March 28, 2025. Its market cap has increased by 14.21% in one year.
Market Cap
11.31M
Enterprise Value
-6.07M
1-Year Change
14.21%
Ranking
Category
Stock Price
3.04
Market Cap Chart
Since December 31, 2001, COSCIENS Biopharma's market cap has decreased from $167.20M to $11.31M, a decrease of -93.24%. That is a compound annual growth rate of -10.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 9.50M | 10.47% |
| Dec 31, 2024 | 8.60M | -4.44% |
| Dec 29, 2023 | 9.00M | -41.56% |
| Dec 30, 2022 | 15.40M | -64.27% |
| Dec 31, 2021 | 43.10M | 61.42% |
| Dec 31, 2020 | 26.70M | 78.00% |
| Dec 31, 2019 | 15.00M | -68.94% |
| Dec 31, 2018 | 48.30M | 58.36% |
| Dec 29, 2017 | 30.50M | -14.57% |
| Dec 30, 2016 | 35.70M | 1,131.03% |
| Dec 31, 2015 | 2.90M | -89.34% |
| Dec 31, 2014 | 27.20M | -22.29% |
| Dec 31, 2013 | 35.00M | -15.87% |
| Dec 31, 2012 | 41.60M | -67.60% |
| Dec 30, 2011 | 128.40M | 18.34% |
| Dec 31, 2010 | 108.50M | 152.91% |
| Dec 31, 2009 | 42.90M | 65.00% |
| Dec 31, 2008 | 26.00M | -68.25% |
| Dec 31, 2007 | 81.90M | -61.96% |
| Dec 29, 2006 | 215.30M | -7.56% |
| Dec 30, 2005 | 232.90M | -17.99% |
| Dec 31, 2004 | 284.00M | 133.74% |
| Dec 31, 2003 | 121.50M | 16.49% |
| Dec 31, 2002 | 104.30M | -37.62% |
| Dec 31, 2001 | 167.20M | - |
View and export this data all the way back to 2001.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 737.63B |
| UnitedHealth Group | 471.74B |
| Johnson & Johnson | 393.12B |
| AbbVie | 358.61B |
| Novo Nordisk | 308.71B |
| Abbott Laboratories | 227.80B |
| AstraZeneca | 225.00B |
| Merck & Co. | 221.28B |